The primary goal of this study was to determine accuracy for diagnosing acutely decompensated heart failure (ADHF) in the undifferentiated dyspneic ED patient using a Lung and Cardiac Ultrasound (LuCUS) protocol. Secondary objectives were to determine if ultrasound findings acutely change management and if findings are more accurate than clinical gestalt. Methods: This was a prospective, observational study of adult patients presenting to the ED with undifferentiated dyspnea. Intervention consisted of a twelve-view LuCUS protocol performed by experienced emergency physician (EP) sonographers. The primary objective was measured by comparing ultrasound findings to final diagnosis independently determined by two blinded physicians. Acute treatment changes based on ultrasound findings were tracked in real time through a standardized data collection form. Results: We analyzed data on 99 patients; 36% had a final diagnosis of ADHF. The overall sensitivity, specificity, positive and negative likelihood ratios of the LuCUS protocol were 83% (67-93 95% confidence interval [CI]), 83% (70-91 CI), 4.8 (2.7-8.3 CI) and 0.20 (0.09 -0.42 CI), respectively. 47% of patients had changes in acute management, and 42% had changes in acute treatment. Observed agreement for the LuCUS protocol was 93% between coinvestigators. Overall, accuracy improved by 20% (83% vs 63%, 8-31 CI of the difference) over clinical gestalt alone.
INTRODUCTION
Dyspnea, one of the most common complaints evaluated in the emergency department (ED), has multiple and varied etiologies. In the United States, with five million people carrying a diagnosis of heart failure, and an additional 650 thousand diagnosed annually, patients with acute decompensated heart failure (ADHF) account for many of the presentations of acute dyspnea seen in EDs today. 1 Early diagnosis and goaldirected therapies are necessary for these patients in order to increase the efficacy and appropriateness of management, avoid unnecessary and potentially harmful interventions, as well as avoid delays in care. For example, the use of inhaled bronchodilators, in patients with undifferentiated dyspnea later found to have ADHF, is associated with worse outcomes. 2 Traditional work up for ADHF, using chest radiography and serum brain natriuretic peptide, is not always diagnostic or helpful in elucidating the cause of dyspnea and has an overall diagnostic accuracy of only 65%. [3] [4] [5] [6] [7] Bedside ultrasonography may play a role in the management of patients with undifferentiated dyspnea by allowing early diagnosis of ADHF or by identifying alternative etiologies. Multiple prior studies have attempted to differentiate ADHF by using lung ultrasound alone to detect pulmonary edema, which appears as diffuse B-lines, also termed alveolar interstitial syndrome (AIS). 3, 5, 6, [8] [9] [10] [11] This finding on bedside ultrasound is highly sensitive for ADHF, 3, [9] [10] [11] [12] [13] but lacks specificity as diffuse B-lines can be seen in a number of conditions including but not limited to, ADHF, non-cardiogenic pulmonary edema, bilateral pneumonia/pneumonitis, and lung cancer. 3, 8, 10, 14 Collapsibility and diameter variation with inspiration of the inferior vena cava (IVC) has been extensively studied independently of lung ultrasound. 1, 15, 16 Smaller variations in IVC diameter reflect elevated central venous pressure, a finding with a high sensitivity for detection of ADHF. 1 However, this finding also lacks specificity as 3 elevated central venous pressure can be seen in cardiac tamponade, pulmonary embolism, and valvular heart disease. 1 Kajimoto et al were the first to assess lung, cardiac and IVC ultrasound to differentiate ADHF from other causes of dyspnea. 17 They found their scanning protocol to be highly sensitive and specific for diagnosing ADHF when performed by cardiology, and more accurate than lung ultrasound alone. Anderson et al later used a protocol similar to the Kajimoto study and found a specificity of 100% for diagnosing ADHF. 18 Our study is similar to these two prior studies in that we also used a scanning protocol, composed of lung, cardiac and IVC ultrasound, to diagnose ADHF. However, our study is the first to evaluate the direct impact of ultrasound findings on acute management of dyspneic patients. Also, we chose to evaluate for the presence of pleural effusions, the presence of diastolic cardiac dysfunction, and patients previously treated (within 30 minutes) for ADHF. We chose to include these additional elements in an effort to improve sensitivity for detecting ADHF and allow greater real world application.
The primary aim of this study was to determine the sensitivity, specificity and likelihood ratios for diagnosing ADHF in the undifferentiated dyspneic ED patient using a twelve-view Lung and Cardiac Ultrasound (LuCUS) protocol. Our secondary aims were to determine if ultrasound findings acutely change management and if these findings were more accurate then clinical gestalt alone. We hypothesize that the use of this diagnostic protocol will increase accuracy for diagnosing ADHF and acutely improve clinical management.
METHODS

Study Design and Setting
This was a prospective, observational study on the diagnostic performance of the LuCUS protocol to diagnose ADHF in ED patients with undifferentiated dyspnea. This study was conducted at an urban tertiary-care teaching hospital with over 120,000 annual ED visits and was approved by the Institutional Review Board.
Study Population
4
We enrolled a convenience sample of patients meeting the inclusion criteria: adult patients over 18-years-old and a primary complaint of undifferentiated dyspnea according to their treating clinician. We defined undifferentiated dyspnea as at least two possible etiologies in the differential diagnosis, and this did not have to include ADHF as a potential diagnosis. 
Intervention and Data Collection
After initial history, physical exam, and 12 lead electrocardiogram, but prior to ultrasound, treating clinicians were asked by a research assistant to rank ten possible etiologies of dyspnea in order of their likelihood (Table 1) Sonographers were blinded to the treating clinician's initial assessment, patients' comorbidities, and the results of lab tests or imaging studies performed during the patients' ED encounter.
The LuCUS Protocol
Each sonographer conducted a two-part scanning protocol using a Mindray M7 ultrasound machine. Patients were in a position of comfort, semi-recumbent, and as close to 30 degrees of head-elevation as possible.
The lung portion of the LuCUS exam interrogated four anterior/lateral lung zones in each hemi-thorax with a curvilinear probe. 14 Sonographers recorded the number of B-lines seen between two ribs in each lung zone. Greater than three B-lines in a rib space was considered a "B-profile". An exam that had at least two zones, in each hemi-thorax, with a B-profile was considered positive for diffuse B-lines or AIS. 4, 19 The cardiac portion of the LuCUS exam consisted of the following views:
1. Subxiphoid view: examined IVC diameter and collapsibility during inspiration in the long axis. The IVC diameter was measured two centimeters caudal to the hepatic vein inlet 20 , using M mode with the cursor placed perpendicular to the IVC. An IVC with a maximal diameter ≥2 cm and < 50% collapse was considered plethoric. An IVC with a maximal diameter ≤ 2 cm and > 50% collapse was considered collapsible. Intermediate was defined as an IVC that did not fit either criteria.
Parasternal long and short-axis views: left ventricular ejection fraction was estimated
visually in the parasternal long-axis view by wall contraction and thickening 21, 22 .
Ejection fraction was confirmed in the parasternal short-axis view at the level of the papillary muscles. Approximately two-thirds of images were randomly selected for blind review by a cardiologist board-certified in echocardiography to assess inter-observer reliability for identifying and grading diastolic dysfunction.
Outcome Measures
Demographic information was collected including patient's age, gender and comorbidities. We also collected vital signs at presentation, admission diagnosis, cardiac biomarkers obtained in the ED and ED interventions. This information was abstracted by research assistants, trained in data abstraction according to recommendations from a previously published study. 27 Abstractors were blinded to ultrasound results and final discharge diagnosis.
ADHF was defined sonographically as a combination of the following findings: 
Data Analysis
A pilot study using the LuCUS protocol was conducted, enrolling twenty ED patients with undifferentiated dyspnea. Analysis of the pilot data showed LuCUS to be 25% more sensitive and 24% more specific for diagnosing ADHF than for patients in whom ultrasound was not used. From these results, we calculated based on a paired comparison, that a sample size of 96 patients would be needed to detect a 30% increase in accuracy with an α of 0.05 and a β of 0.20. Sensitivity, specificity, positive likelihood ratios and negative likelihood ratios were calculated and 95% confidence intervals (CIs)
were derived using SPSS Statistics for Windows (IBM Corp Version 21.0, Armonk, NY).
A sub-analysis (Table 3 ) was completed to see which variables, including B-lines, pleural effusions, IVC assessment, and LV function, yielded the highest accuracy. Kappa and observed agreement were used to assess inter-rater reliability between coinvestigators'
interpretations of images. Kappa was also used to assess agreement between EPs' and cardiology's grading of diastolic dysfunction.
RESULTS
Between December 2012 and July 2013, the LuCUS protocol was performed on 104 patients presenting to the ED with undifferentiated dyspnea. Demographic and clinical information are listed in Table 2 . The flow of the study is presented in Figure 2 .
A total of five patients were excluded, in four patients the ultrasound was not feasible due to poor scanning windows and body habitus, and one patient dropped out of the study prior to completion of the ultrasound. 
Pre-Ultrasound (Clinical Gestalt)
ADHF was listed amongst the top three etiologies in the differential diagnosis in 69 (70%) out of 99 patients. Of these 69 patients, 34 (49%) had a criterion standard diagnosis of ADHF and 35 (51%) had an alternative diagnosis (Figure 3) . Thus, the sensitivity and specificity of clinical gestalt was 94 and 44, respectively.
Post-Ultrasound (LuCUS Protocol)
ADHF was listed as one of the top three etiologies in the differential diagnosis in 41 (41%) out of 99 patients. Of these 41, 30 (73%) had a criterion standard diagnosis of ADHF and 11 (27%) had an alternative diagnosis ( Figure 2 ).
Comparison of Pre to Post-Ultrasound
Of the initial 69 patients thought to have ADHF pre-ultrasound: 30 Fifty-one out of 99 patients (51%) had a pre-ultrasound differential diagnosis that included both ADHF and COPD. Out of these 51 patients, 25 (49%) had changes in ED administered medications. These results are summarized in Table 4 . 
DISCUSSION
Dyspnea is a common complaint in the ED and rapidly identifying the cause can pose a challenge for clinicians. In this study we found the LuCUS protocol improved diagnostic accuracy over clinical gestalt alone, including improved specificity, which was statistically significant. Clinical gestalt was more sensitive for the diagnosis of ADHF, but did not reach statistical significance. We believe clinical gestalt had such a high sensitivity due to ADHF being over-diagnosed. This is illustrated by the fact that over fifty percent of the patients thought to have ADHF based on clinical gestalt (preultrasound) were ultimately found to have an alternative criterion standard diagnosis.
The LuCUS protocol had 6 false negative results. Two of these patients were thought to have atrial fibrillation as the primary etiology of dyspnea pre-ultrasound, the LuCUS protocol found a mixed diagnosis, which was defined as two etiologies contributing equally to the patient's clinical symptoms. In these two cases, ADHF was one of the two etiologies, so these ultrasounds were coded as a "mixed" diagnosis and not as ADHF alone. However, both of these patients were treated appropriately with diuresis. If these ultrasounds had been coded as ADHF instead of a mixed diagnosis, the sensitivity would have improved from 83 to 89% (75-95 CI). In the subset of patients thought to have both ADHF and COPD pre-ultrasound, 24 out of 25 patients (96%) received correct disease-specific treatment post-ultrasound.
Based on clinical gestalt, twelve out of these 25 patients (48%) were thought to have COPD and thus were treated with beta agonists and steroids; after LuCUS diagnosed ADHF, beta agonists were correctly discontinued. Final diagnosis confirmed that these patients had ADHF, not COPD.
This protocol not only differentiated patients with ADHF versus COPD, but it also identified alternative causes of dyspnea requiring very different treatment. For example, one patient thought to have ADHF based on clinical gestalt, was diagnosed post-ultrasound with a large pericardial effusion with early tamponade physiology and was taken immediately for drainage.
The findings of the LuCUS protocol are similar to other previous studies that investigated the utility of bedside ultrasound for diagnosing ADHF. However, there are several aspects of our study that make it unique. The study by Kajimoto et al 17 differs from ours in that their protocol was performed by trained cardiologists, thus limiting its utilization by EP's. Also, we included patients treated for ADHF prior to ultrasound to allow for better real-world application. The results of our study show that our protocol can be accurately applied in this subset of patients. We also evaluated the direct impact of ultrasound findings on acute management of dyspneic patients and found that the LuCUS protocol lead to correct disease-specific treatment in the vast majority of treated patients.
The LuCUS protocol utilized four unique elements that differ from prior protocols: (1) we included patients treated for ADHF before ultrasound, (2) we used bilateral B-profiles, rather than AIS, as a potential indicator of ADHF, (3) we evaluated for pleural effusions, and (4) we assessed and graded diastolic dysfunction.
We chose to include patients who had been treated less than 30 minutes prior to ultrasound as we thought this was more applicable to daily practice, as patients may be treated by EMS or other front-end providers prior to initial evaluation by an EP. We found in this subset of patients the LuCUS protocol to be 100% accurate. These results suggest that we can apply this protocol in patients who have been treated for heart failure within 30 minutes.
Using B-profiles and/or pleural effusions as potentially indicative of ADHF allowed us to apply our protocol to a much larger group of patients than previous similar studies. While it is well established that the presence of AIS is fairly sensitive for detecting ADHF, 3, 8, 10, 14 it is possible to have ADHF without AIS. By using this definition, we found a bilateral B profile and ejection fraction <45% improved sensitivity for detecting ADHF by 35% (69% vs 34%, 11-53 CI of the difference) compared to AIS with ejection fraction < 45%.
Although previous literature would support the conclusion that pleural effusions do not improve diagnostic performance, 10 we chose to include pleural effusions as part of the protocol, as we hypothesized that their inclusion may improve the protocol's overall accuracy, especially after commencement of treatment. We found the presence of a pleural effusion combined with an ejection fraction < 45% to be 98% specific for ADHF, with a positive likelihood ratio of 51.
Even though we were able to detect diastolic dysfunction 100% of the time, there was only moderate agreement between EPs and cardiology for grading the level of dysfunction. Its assessment in our study did not lead to substantive improvements in recognition of ADHF, as only 2 out of the 36 patients (5%) with a final diagnosis of ADHF had isolated diastolic dysfunction. However, we believe evaluation of diastolic function represents an area for future investigations as patients with isolated diastolic dysfunction will present to the ED in ADHF and are likely to benefit from early recognition of this as the etiology of their dyspnea.
This study has shown that EP sonographers with extensive ultrasound experience can make an accurate diagnosis of ADHF, more accurate then clinical gestalt alone, and this in turn can improve patient care. Future directions for this research would include assessing a modified protocol with less experienced sonographers to further validate the results and to improve its generalizability.
LIMITATIONS
This study has several limitations that could limit its generalizability. We enrolled a convenience sample of patients at a single institution, which may have introduced selection bias, as one of the expert sonographers need to be available for enrollment. In addition, despite being powered to detect a clinically significant improvement in accuracy, the overall sample size was small.
The gold standard for diagnosing ADHF is comprehensive echocardiography in combination with clinical symptoms and therapeutic response. Due to limited resources, however, not all patients enrolled in the study had a comprehensive echocardiogram. If it was performed, it was often not completed in a rapid manner, sometimes not occurring until days after admission, thereby limiting its utility as a gold standard. For our study, the gold standard was the final diagnosis determined by two independent expert reviewers; this model has served as criterion standard in multiple previous heart failure studies. 1, 11, [29] [30] [31] It is possible that results of the bedside ultrasound, directly or indirectly, were included in patients' ED chart and thus could act as a potential source of bias for the chart reviewers. However, our experience is that this is an infrequent practice at this institution and thus we feel the risk for bias is minimal. Also, BNP levels were not analyzed for this study as not enough patients had levels available, although it was not a requirement for enrollment as its use in the acute setting is not as well supported. 32 Due to limitations imposed by the institutional review board, treating clinicians were not blinded to ultrasound results as the use of bedside sonography by EPs is considered standard care our institution. Thus, subsequent management may reflect results of the ultrasound and therefore the treatment record may not be independent of the diagnostic test, which may have influenced the chart reviewers' determination of final diagnosis. Furthermore, sonographers may have been biased as they could not be blinded to the physical appearance of patients. However, we believe that this would be of minimal significance as patients were covered, we did not perform a physical exam, and clinical gestalt, including physical assessment, has been proven to be unreliable for determining etiology of dyspnea. 18, 33 Lastly, this study was designed as an expert-level study with future goals of prospective validation using less experienced sonographers.
CONCLUSIONS
In summary, our findings indicate that the LuCUS protocol, when performed by an experienced EP-sonographer in the assessment of ED patients with undifferentiated dyspnea, may accurately identify ADHF in dyspneic ED patients and increase the rate of correct, disease-specific treatment decisions.
This protocol has better diagnostic accuracy than clinical gestalt alone and increases physician confidence in their diagnosis. 
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